NERM
OGN icon

New England Research & Management’s Organon & Co OGN Stock Holding History

New England Research & Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,092
Closed -$308K – 173
2024
Q3 		$308K Sell
16,092
-752
-4% -$15.6K 0.14% 135
2024
Q2 		$349K Sell
16,844
-1,425
-8% -$28.3K 0.17% 146
2024
Q1 		$343K Sell
18,269
-252
-1% -$4.32K 0.17% 135
2023
Q4 		$267K Sell
18,521
-405
-2% -$5.51K 0.14% 145
2023
Q3 		$329K Sell
18,926
-3,000
-14% -$62.6K 0.19% 122
2023
Q2 		$456K Sell
21,926
-125
-0.6% -$2.72K 0.26% 98
2023
Q1 		$519K Sell
22,051
-12,478
-36% -$335K 0.3% 105
2022
Q4 		$964K Buy
34,529
+14,800
+75% +$378K 0.55% 70
2022
Q3 		$462K Buy
+19,729
New +$596K 0.29% 106

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New England Research & Management's OGN Position: Q4 2024 in Review

New England Research & Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 16,092 shares — an estimated $308K sold.

New England Research & Management first reported a position in OGN in Q3 2022 and held it in 9 quarters. The position peaked at $964K in Q4 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • New England Research & Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • New England Research & Management sold 16,092 Organon & Co shares in Q4 2024, an estimated $308K.
  • New England Research & Management first reported a position in Organon & Co in Q3 2022 and held it in 9 quarters.
  • New England Research & Management's Organon & Co position peaked at $964K in Q4 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on New England Research & Management's 13F filing for Q4 2024, filed 23 Jan 2025.